Labcorp, the company behind Labcorp stock, sets results date

Published on 10/01/2026 at 13:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Labcorp, the company behind Labcorp stock, guides to USD 18.10-18.55 for 2026. Third-quarter results are due October 28, 2026 at 9:00 a.m. ET.

Aquarellbild eines gläsernen Bürogebäudes vor Skyline in Pastelltönen — Aquarellmalerei einer Stadtlandschaft mit gläsernem Firmensitz symbolisiert Labcorp, ISIN US50540R4092, im Gesundheitssektor, Illustration mit AI erstellt.

Labcorp, the company behind Labcorp stock, will publish third-quarter 2026 results on October 28, 2026, before the NYSE opens. According to Labcorp on September 30, 2026, the company will hold its results webcast at 9:00 a.m. ET.

October results date is set

The scheduled release gives investors a defined checkpoint for the company's 2026 operating plan. The event will cover the third quarter, while the latest available quarterly figures show revenue of USD 3.7311 billion and diluted earnings per share of USD 3.64 for the second quarter of 2026.

Labcorp's second-quarter operating profit was USD 451.6 million, with an operating margin of 12.00 percent. Revenue rose from USD 3.5376 billion in the first quarter of 2026 to USD 3.7311 billion in the second quarter, a quarter-over-quarter increase of 5.47 percent.

Guidance points to measured growth

At its September 10, 2026 Investor Day, Labcorp reaffirmed full-year 2026 adjusted earnings per share guidance of USD 18.10-18.55 and enterprise revenue growth guidance of 5.40-6.30 percent. The company also outlined a 2029 target of 5.00-8.00 percent compound annual revenue growth and 8.50-11.50 percent compound annual adjusted earnings per share growth.

The guidance range matters because it links the October report to a broader plan rather than a single quarter. Labcorp also expects full-year 2026 free cash flow of USD 1.24 billion-1.36 billion, giving investors a second operating measure to compare with the earnings release.

Market value frames the report

Labcorp's market capitalization stood at USD 25.3 billion as of September 30, 2026. Its 52-week range was USD 244.52-341.80, placing the upcoming report against a broad valuation corridor rather than a single price point.

Labcorp is listed on the NYSE under ticker LH. Its business spans Diagnostics Laboratories and Biopharma Laboratory Services, so the third-quarter release can show whether the revenue trend is broad-based across both operating areas.